APTO News and Press, Aptose Biosciences Inc. From 11/05/19

CG-806 Mutation Agnostic FLT3/BTK Inhibitor and APTO-253 MYC Inhibitor Safely Dose Escalate CLL Patient Treated with Second Dose Level of CG-806 Shows Evidence of Clinical Response Conference Call and Webcast at 5pm EDT Today SAN DIEGO and TORONTO, Nov. 05, 2019 (GLOBE NE...

SAN DIEGO and TORONTO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer cells and address unmet medical needs of...

SAN DIEGO and TORONTO, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today anno...

The following slide deck was published by Aptose Biosciences Inc. in conjunction with this Read more ...

SAN DIEGO and TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today a...

Aptose Biosciences Inc. (APTO) Q2 2019 Results Conference Call August 06, 2019 05:00 PM ET Company Participants Susan Pietropaolo - Investor Relations William Rice - Chairman, President and Chief Executive Officer Gregory Chow - Executive Vice President and Chief Financial Office...

Aptose Biosciences (NASDAQ: APTO ): Q2 GAAP EPS of -$0.13 beats by $0.02 . More news on: Aptose Biosciences Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

─  APTO-253 Inhibits MYC in AML and MDS Patients in Phase 1 Clinical Trial ─ ─  First CLL Patient Dosed with CG-806 in Phase 1 Clinical Trial ─ Conference Call and Webcast at 5pm EDT Today SAN DIEGO and TORONTO, Aug. 06, 2019 (GLOBE NEWSW...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...